Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Enzon acquires Genex for $6.1M to expand PEGNOLOGY

Executive Summary

Enzon (biopharmaceutical company developing proprietary drug delivery systems) acquired Genex (protein engineering company) for approximately 701,000 shares of Enzon common stock, worth $6.1 million and 583,000 three year warrants.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition

Related Companies